ZA200802436B - Composition comprising a NSAID and paracetamol - Google Patents

Composition comprising a NSAID and paracetamol

Info

Publication number
ZA200802436B
ZA200802436B ZA200802436A ZA200802436A ZA200802436B ZA 200802436 B ZA200802436 B ZA 200802436B ZA 200802436 A ZA200802436 A ZA 200802436A ZA 200802436 A ZA200802436 A ZA 200802436A ZA 200802436 B ZA200802436 B ZA 200802436B
Authority
ZA
South Africa
Prior art keywords
paracetamol
nsaid
composition
Prior art date
Application number
ZA200802436A
Other languages
English (en)
Inventor
Sherry Robert
Original Assignee
Uk Reckitt Benckiser Healthcar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35335274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200802436(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uk Reckitt Benckiser Healthcar filed Critical Uk Reckitt Benckiser Healthcar
Publication of ZA200802436B publication Critical patent/ZA200802436B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200802436A 2005-09-22 2008-03-17 Composition comprising a NSAID and paracetamol ZA200802436B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519350.3A GB0519350D0 (en) 2005-09-22 2005-09-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA200802436B true ZA200802436B (en) 2009-07-29

Family

ID=35335274

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802436A ZA200802436B (en) 2005-09-22 2008-03-17 Composition comprising a NSAID and paracetamol

Country Status (13)

Country Link
US (1) US20090142392A1 (fr)
EP (2) EP1926477B1 (fr)
JP (1) JP2009508916A (fr)
KR (2) KR101434906B1 (fr)
CN (1) CN101267807B (fr)
AU (1) AU2006293798B2 (fr)
CA (1) CA2623281A1 (fr)
GB (1) GB0519350D0 (fr)
PL (2) PL1926477T3 (fr)
RU (1) RU2438656C2 (fr)
SG (1) SG149080A1 (fr)
WO (1) WO2007034135A1 (fr)
ZA (1) ZA200802436B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
AP2010005341A0 (en) * 2008-01-11 2010-08-31 Cipla Ltd Solid pharmaceutical dosage form
WO2009128543A1 (fr) * 2008-04-17 2009-10-22 ニプロ株式会社 Procédé de fabrication d'un comprimé contenant de la silice, comprimé et particule composite pour le comprimé
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
WO2019108147A1 (fr) 2017-11-29 2019-06-06 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Association d'ibuprofène et de paracétamol en comprimés à doses fixes et à couleur stable
US20190350883A1 (en) * 2018-05-20 2019-11-21 Luan Chau Pharmaceutical Composition of Acetaminophen/Ibuprofen
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form
PH12021553169A1 (en) 2019-06-27 2022-08-15 Glaxosmithkline Consumer Healthcare Holdings Us Llc Novel ibuprofen and acetaminophen composition
CN110372713B (zh) * 2019-08-15 2022-05-17 广州市汉普医药有限公司 一种普拉洛芬的精制纯化方法
WO2023281089A2 (fr) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Composition pharmaceutique comprenant du naproxène et du paracétamol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802619C1 (fr) 1988-01-29 1989-09-07 Hoechst Ag, 6230 Frankfurt, De
US5271811A (en) * 1988-01-29 1993-12-21 Hoechst Celanese Corporation Process for purifying 2-(4-isobutylphenyl)-propionic acid by vacuum distillation
DE3833448A1 (de) 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
DE4418837A1 (de) 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
JP3982889B2 (ja) * 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
RU2192248C2 (ru) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Препарат "антигриппин"
US8124124B2 (en) * 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
GB0113841D0 (en) 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
KR101482922B1 (ko) * 2004-08-12 2015-01-15 레킷트 벵키저 헬스케어(유케이)리미티드 용융 압출에 의해 제조된, ｎｓａｉｄ와 당 알콜을 포함하는 과립
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
WO2007034135A1 (fr) 2007-03-29
SG149080A1 (en) 2009-01-29
GB0519350D0 (en) 2005-11-02
JP2009508916A (ja) 2009-03-05
EP1926477B1 (fr) 2017-04-19
RU2438656C2 (ru) 2012-01-10
AU2006293798A1 (en) 2007-03-29
US20090142392A1 (en) 2009-06-04
RU2008115507A (ru) 2009-10-27
KR20130141728A (ko) 2013-12-26
EP1926477A1 (fr) 2008-06-04
EP2851068A2 (fr) 2015-03-25
EP2851068A3 (fr) 2015-05-27
PL2851068T3 (pl) 2020-04-30
CN101267807B (zh) 2013-04-10
CA2623281A1 (fr) 2007-03-29
PL1926477T3 (pl) 2017-09-29
AU2006293798B2 (en) 2012-08-16
KR20080047437A (ko) 2008-05-28
EP2851068B1 (fr) 2019-10-23
CN101267807A (zh) 2008-09-17
KR101434906B1 (ko) 2014-08-27

Similar Documents

Publication Publication Date Title
EP1744757A4 (fr) Composition ains amelioree
GB0413730D0 (en) A pharmaceutical composition and its use
TWI372755B (en) Isoxazoline-substituted benzamide compound and pesticide
IL179795A0 (en) A pharmaceutical composition and its use
IL184324A0 (en) Pyy agonists and uses thereof
EP1942171A4 (fr) Matériau de dispositif électroluminescent et dispositif électroluminescent
SI2957278T1 (sl) Stabilni sestavek, ki obsega PTHrP, in njegova uporaba
ZA200902189B (en) Phenylpropionamide compounds and the use thereof
GB0512940D0 (en) Compounds and their use
IL176923A0 (en) Structured materials and methods
EP1942108A4 (fr) Compose contenant un groupe basique et son utilisation
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1890677A4 (fr) Compositions pharmaceutiques et leur utilisation
IL185223A0 (en) Compounds and uses thereof
GB0516069D0 (en) Pharmaceutical and use thereof
IL179497A0 (en) Carboranylporphyrins and uses thereof
GB0520743D0 (en) Compounds and their use
GB0508670D0 (en) Structured packing and use thereof
EP1899370A4 (fr) Structure cristalline et son utilisation
GB0526031D0 (en) Use
GB0603717D0 (en) Electricity-generate and store
GB0804899D0 (en) Compound composition and use
GB0505620D0 (en) Methods and materials therefor
ZA200804378B (en) Iminopropene compound and use thereof
GB0608797D0 (en) Novel agents and the use thereof